Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Levine

Showing results (681-690 of 751) with videos related to

Pageof 76
Sort By:
Annals of Internal Medicine|July 8, 2009
Positron emission tomography in staging early lung cancer: a randomized trialDonna E Maziak, Gail E Darling, Richard I Inculet, et al.
The New England Journal of Medicine|February 12, 2010
Long-term results of hypofractionated radiation therapy for breast cancerTimothy J Whelan, Jean-Philippe Pignol, Mark N Levine, et al.
British Journal of Cancer|August 19, 2015
TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trialJ M S Bartlett, T O Nielsen, D Gao, et al.
JAMA Cardiology|February 22, 2018
In-Hospital ST-Segment Elevation Myocardial Infarction: Improving Diagnosis, Triage, and TreatmentGlenn N Levine, Xuming Dai, Timothy D Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancerMargot Burnell, Mark N Levine, Judith-Anne W Chapman, et al.
The American Journal of Sports Medicine|April 15, 2025
Pitch-Specific Advanced Analytic and Pitch-Tracking Risk Factors for Ulnar Collateral Ligament Injuries in Major League Baseball PitchersMichael A Mastroianni, Jennifer A Kunes, John D Mueller, et al.
Journal of Veterinary Internal Medicine|January 11, 2024
A prospective cohort study to identify clinical diagnostic and prognostic markers of primary immune thrombocytopenia in dogsMarjory B Brooks, Robert Goggs, Amelia H Frye, et al.
JACC. Advances|November 14, 2024
Vital Exhaustion and Biomarkers Associated With Cardiovascular Risk: The ARIC StudyMatthew R Deshotels, Mahmoud Al Rifai, Caroline Sun, et al.
Journal of the American Heart Association|October 1, 2017
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart AssociationGlenn N Levine, Richard A Lange, C Noel Bairey-Merz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2011
Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trialGail E Darling, Donna E Maziak, Richard I Inculet, et al.
Pageof 76

Showing results (681-690 of 751) with videos related to

Sort By:
Pageof 76
Annals of Internal Medicine|July 8, 2009
Positron emission tomography in staging early lung cancer: a randomized trialDonna E Maziak, Gail E Darling, Richard I Inculet, et al.
The New England Journal of Medicine|February 12, 2010
Long-term results of hypofractionated radiation therapy for breast cancerTimothy J Whelan, Jean-Philippe Pignol, Mark N Levine, et al.
British Journal of Cancer|August 19, 2015
TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trialJ M S Bartlett, T O Nielsen, D Gao, et al.
JAMA Cardiology|February 22, 2018
In-Hospital ST-Segment Elevation Myocardial Infarction: Improving Diagnosis, Triage, and TreatmentGlenn N Levine, Xuming Dai, Timothy D Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancerMargot Burnell, Mark N Levine, Judith-Anne W Chapman, et al.
The American Journal of Sports Medicine|April 15, 2025
Pitch-Specific Advanced Analytic and Pitch-Tracking Risk Factors for Ulnar Collateral Ligament Injuries in Major League Baseball PitchersMichael A Mastroianni, Jennifer A Kunes, John D Mueller, et al.
Journal of Veterinary Internal Medicine|January 11, 2024
A prospective cohort study to identify clinical diagnostic and prognostic markers of primary immune thrombocytopenia in dogsMarjory B Brooks, Robert Goggs, Amelia H Frye, et al.
JACC. Advances|November 14, 2024
Vital Exhaustion and Biomarkers Associated With Cardiovascular Risk: The ARIC StudyMatthew R Deshotels, Mahmoud Al Rifai, Caroline Sun, et al.
Journal of the American Heart Association|October 1, 2017
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart AssociationGlenn N Levine, Richard A Lange, C Noel Bairey-Merz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2011
Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trialGail E Darling, Donna E Maziak, Richard I Inculet, et al.
Pageof 76